Mohan P. Joshi

MSH/SIAPS | Principal Technical Advisor and Cluster Lead for Pharmaceutical Services

Mohan P. Joshi, MBBS, MSc, MD, has worked for Management Sciences for Health (MSH) since 2003. As principal technical advisor and cluster lead for pharmaceutical services under the US Agency for International Development (USAID)-supported Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program of MSH, Dr. Joshi is responsible for providing technical guidance and support in the planning and implementation of rational medicine use and antimicrobial resistance (AMR)-related activities. From July 2007 to 2011, he was Senior Technical Manager for AMR under the Strengthening Pharmaceutical Systems (SPS) Program, which was the predecessor to SIAPS. Dr. Joshi also served as SPS Country Program Manager for Vietnam and Jordan. Prior to July 2007, he was AMR Program Manager for SPS’s predecessor program, Rational Pharmaceutical Management (RPM) Plus. Over a period of 12 years, Dr. Joshi has managed cumulative AMR-related funding of over $8 million.

Before joining MSH, Dr. Joshi worked at the Tribhuvan University (TU) Institute of Medicine and TU Teaching Hospital in Nepal in various capacities, serving as academic assistant dean, professor and head of the Department of Clinical Pharmacology, chief founder of the Drug Information Service, and coordinator of the Hospital Drug Committee. Dr. Joshi has provided technical assistance to Nepal’s Ministry of Health as a member of the Drug Advisory Committee, the Nepal Medical Council, and the Committee for the Revision of the National List of Essential Drugs. Additional experience includes service on the International Health Advisory Panel of the US Pharmacopeia and on the Executive Committee of the Pharmacy Information Section of the International Pharmaceutical Federation. Dr. Joshi was awarded “Education Medal” in 2002 by the Ministry of Education of Nepal.

Dr. Joshi has experience and interest in AMR, rational medicine use, essential medicines lists, standard treatment guidelines, drug use review, drug information, hospital formularies, drug and therapeutics committees, continuous quality improvement, pharmacovigilance, medicine adherence, clinical pharmacology, pharmacotherapy, curriculum review, and medical education.